MPox Study
The purpose of this study is to find out how often health events occur after an Imvamune (Mpox) vaccine
Location: British Columbia and Ontario
Study participants were asked to complete an online survey one week after each dose of vaccine and 30 days after their last dose of vaccine. Participants received an email 8 days after their Mpox vaccination inviting them to respond to a survey. They received another survey approximately 30-60 days after their last Mpox vaccine dose to capture events occurring more than 1 week after vaccination.
Telephone follow up may have been required for those who report an event. The second dose survey (sent 8 days after the second dose) will collect information on AE occurring after the second dose.